다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of agricultural and food chemistry, v.64 no.18, 2016년, pp.3557 - 3563
Inagaki, Hiroyuki , Ito, Ryouichi , Setoguchi, Yuko , Oritani, Yukihiro , Ito, Tatsuhiko
AI-Helper
Piceatannol is polyphenolic antioxidant found in passion fruit (Passiflora edulis) seeds. The aim of this study was to improve the absorption of piceatannol using α-cyclodextrin (αCD). The solubility of piceatannol in neutral and acidic solutions increased in an αCD concentration-d...
Matsui, Yuko, Sugiyama, Kenkichi, Kamei, Masanori, Takahashi, Toshio, Suzuki, Tamio, Katagata, Yohtaro, Ito, Tatsuhiko. Extract of Passion Fruit (Passiflora edulis) Seed Containing High Amounts of Piceatannol Inhibits Melanogenesis and Promotes Collagen Synthesis. Journal of agricultural and food chemistry, vol.58, no.20, 11112-11118.
Sano, Shoko, Sugiyama, Kenkichi, Ito, Tatsuhiko, Katano, Yumi, Ishihata, Akira. Identification of the Strong Vasorelaxing Substance Scirpusin B, a Dimer of Piceatannol, from Passion Fruit (Passiflora edulis) Seeds. Journal of agricultural and food chemistry, vol.59, no.11, 6209-6213.
Kinoshita, Y., Kawakami, S., Yanae, K., Sano, S., Uchida, H., Inagaki, H., Ito, T.. Effect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells. Biochemical and biophysical research communications, vol.430, no.3, 1164-1168.
Maruki-Uchida, Hiroko, Kurita, Ikuko, Sugiyama, Kenkichi, Sai, Masahiko, Maeda, Kazuhisa, Ito, Tatsuhiko. The Protective Effects of Piceatannol from Passion Fruit (Passiflora edulis) Seeds in UVB-Irradiated Keratinocytes. Biological & pharmaceutical bulletin, vol.36, no.5, 845-849.
Am. J. Clin. Nutr. Manach C. 230S 81 2005 10.1093/ajcn/81.1.230S
Marín, Laura, Miguélez, Elisa M., Villar, Claudio J., Lombó, Felipe. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties. BioMed research international, vol.2015, 905215-.
Almeida, Luis, Vaz‐da‐Silva, Manuel, Falcão, Amílcar, Soares, Eva, Costa, Raquel, Loureiro, Ana I., Fernandes‐Lopes, Carlos, Rocha, José‐Francisco, Nunes, Teresa, Wright, Lyndon, Soares‐da‐Silva, Patrício. Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers. Molecular nutrition & food research, vol.53, no.suppl1, S7-S15.
Setoguchi, Yuko, Oritani, Yukihiro, Ito, Ryouichi, Inagaki, Hiroyuki, Maruki-Uchida, Hiroko, Ichiyanagi, Takashi, Ito, Tatsuhiko. Absorption and Metabolism of Piceatannol in Rats. Journal of agricultural and food chemistry, vol.62, no.12, 2541-2548.
Roupe, Kathryn A, Yáñez, Jaime A, Teng, Xiao Wei, Davies, Neal M. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. Journal of pharmacy and pharmacology, vol.58, no.11, 1443-1450.
Rupp, C., Steckel, H., Muller, B.W.. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. International journal of pharmaceutics, vol.395, no.1, 272-280.
Vasconcelos, T., Sarmento, B., Costa, P.. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug discovery today, vol.12, no.23, 1068-1075.
Szejtli, J.. Introduction and General Overview of Cyclodextrin Chemistry. Chemical reviews, vol.98, no.5, 1743-1754.
Liu, Yinghui, Sun, Changshan, Hao, Yanru, Jiang, Tongying, Zheng, Li, Wang, Siling. Mechanism of Dissolution Enhancement and Bioavailability of Poorly Water Soluble Celecoxib by Preparing Stable Amorphous Nanoparticles. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, vol.13, no.4, 589-.
Xiong, Jing, Guo, Jianxin, Huang, Luosheng, Meng, Boyu, Ping, Qineng. The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats. Drug development and industrial pharmacy, vol.34, no.1, 65-72.
10.1177/0192623307310945
Salústio, Paulo José, Pontes, Patrícia, Conduto, Claúdia, Sanches, Inês, Carvalho, Catarina, Arrais, João, Marques, Helena M. Cabral. Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled Release. AAPS PharmSciTech, vol.12, no.4, 1276-1292.
10.3109/10837450.2014.971377
Loftsson, Thorsteinn, Brewster, Marcus E.. Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization. Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, vol.85, no.10, 1017-1025.
Carrier, R.L., Miller, L.A., Ahmed, I.. The utility of cyclodextrins for enhancing oral bioavailability. Journal of controlled release : official journal of the Controlled Release Society, vol.123, no.2, 78-99.
Corti, Giovanna, Cirri, Marzia, Maestrelli, Francesca, Mennini, Natascia, Mura, Paola. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, vol.68, no.2, 303-309.
Ahuja, N., Katare, O.P., Singh, B.. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, vol.65, no.1, 26-38.
IUCHI, Akio, NAKAHORI, Yutaka, BOKI, Keito. Uptake of Heterocyclic Aromatic Amine by Insoluble Dietary Fiber in Artificial Gastric and Intestinal Juice. Environmental health and preventive medicine, vol.9, no.2, 47-52.
The Society of Japanese Pharmacopoeia. Disintegration test. In The Japanese Pharmacopoeia,13th ed.Hirokawa Shoten:Tokyo, Japan, 1996; ppB-475-B-484.
Adv. Anal. Chem. Instrum. Higuchi T. 117 4 1965
Nielsen, L.H., Gordon, S., Holm, R., Selen, A., Rades, T., Mullertz, A.. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, vol.85, no.3, 942-951.
Walle, Thomas, Hsieh, Faye, DeLegge, Mark H., Oatis Jr., John E., Walle, U. Kristina. HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS. Drug metabolism and disposition: the biological fate of chemicals, vol.32, no.12, 1377-1382.
Tomé-Carneiro, Joao, Larrosa, Mar, González-Sarrías, Antonio, Tomás-Barberán, Francisco A., García-Conesa, María Teresa, Espín, Juan Carlos. Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence. Current pharmaceutical design, vol.19, no.34, 6064-6093.
PRESCOTT, L.F.. GASTRIC EMPTYING AND DRUG ABSORPTION. British journal of clinical pharmacology, vol.1, no.3, 189-190.
Evans, Allan M.. Influence of Dietary Components on the Gastrointestinal Metabolism and Transport of Drugs :. Therapeutic drug monitoring, vol.22, no.1, 131-136.
Quini, Caio C, Américo, Madileine F, Corá, Luciana A, Calabresi, Marcos FF, Alvarez, Matheus, Oliveira, Ricardo B, Miranda, Jose Ricardo A. Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats. Journal of biological engineering, vol.6, 6-6.
Juan, M. Emília, González-Pons, Eulalia, Planas, Joana M.. Multidrug Resistance Proteins Restrain the Intestinal Absorption of trans-Resveratrol in Rats. The Journal of nutrition, vol.140, no.3, 489-495.
Hirayama, F, Uekama, K. Cyclodextrin-based controlled drug release system. Advanced drug delivery reviews, vol.36, no.1, 125-141.
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-up and Postapproval Changes: Chemistry, Manufacturing, And Controls; In Vitro Dissolution Testing and in Vivo Bioequivalence Documentation; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), September 1997 CMC 8;http://www.fda.gov/cder/guidance/index.htm(accessed January 2016) .
Wang, Qing Li, Lin, Mao, Liu, Geng Tao. Antioxidative Activity of Natural Isorhapontigenin. The Japanese journal of pharmacology : official publication of the Japanese Pharmacological Society, vol.87, no.1, 61-66.
Fang, Yong, Cao, Zipeng, Hou, Qi, Ma, Chen, Yao, Chunsuo, Li, Jingxia, Wu, Xue-Ru, Huang, Chuanshu. Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells. Molecular cancer therapeutics, vol.12, no.8, 1492-1503.
Kawakami, Shinpei, Kinoshita, Yosuke, Maruki-Uchida, Hiroko, Yanae, Koji, Sai, Masahiko, Ito, Tatsuhiko. Piceatannol and Its Metabolite, Isorhapontigenin, Induce SIRT1 Expression in THP-1 Human Monocytic Cell Line. Nutrients, vol.6, no.11, 4794-4804.
Oritani, Y., Okitsu, T., Nishimura, E., Sai, M., Ito, T., Takeuchi, S.. Enhanced glucose tolerance by intravascularly administered piceatannol in freely moving healthy rats. Biochemical and biophysical research communications, vol.470, no.3, 753-758.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.